. Raw traces of recombinant wild type NMDAR recordings. Related to Figure 6 . (A) Examples of responses to 2 ms application of 1 mM glutamate (arrows) for GluN1:GluN2B wild type receptors in outsideout patches. (B) Mean currents evoked by 2 ms applications of 1 mM glutamate. (C) Examples of unitary currents recorded during continuous application of 1 mM glutamate for GluN1:GluN2B receptors from outside-out patches. All NMDA receptors currents were recorded at -100 mV in the continuous presence of 100 µM glycine. 
GluN2B mutant tfast (ms)
tslow ( Table S1 . Kinetic parameters of GluN1:GluN2B Y1252 NMDAR deactivation. Related to Figure 6 . Deactivation kinetic parameters of GluN1:GluN2B diheteromers expressed in tsA201 cells. Recordings were made from outside-out patches stimulated 60 times at 6 s intervals with 2 ms pulses of 1 mM glutamate in the presence of 100 µM glycine. There are no significant difference deactivation kinetics between WT and either mutant receptor. Data were analyzed by one-way ANOVA (tfast p = 0.91, tslow p = 0.70, fraction Islow p = 0.74, tweighted p = 0.93). n = 4 WT, 9 YF, and 8 YE patches, respectively, and data are shown as means ± SEM.
GluN2B mutant o1 (ms) o2 (ms) fraction o2 o-weighted (ms) Conductance (pS) WT 0.29 ± 0.03 3.85 ± 0.02 0.76 ± 0.004 3.01 ± 0.04 45.0 ± 6.0 Y1252F 0.32 ± 0.03 4.16 ± 0.12 0.70 ± 0.04 3.03 ± 0.14 45.6 ± 3.4 Y1252E 0.29 ± 0.06 3.70 ± 0.55 0.66 ± 0.05 2.57 ± 0.42 47.9 ± 1.5 Table S2 . Single channel properties for GluN1:GluN2B Y1252 mutant NMDARs. Related to Figure 6 .
Single-channel open time parameters and conductance of GluN1:GluN2B diheteromers expressed in tsA201 cells. Recordings were made from outside-out patches in the continuous presence of 1 mM glutamate and 100 µM glycine. There are no significant differences in the mean open time or conductance between WT and either mutant receptor. Data were analyzed by one-way ANOVA (weighted open time: p = 0.45; conductance p = 0.84). n = 2 WT, 4 YF, and 3 YE patches, respectively, and data are shown as means ± SEM. Gene  GENE  ID  domain  ∆  pY1252-Y1252 Mean  Count SEM   1  Gst  GST control  825  8  3658  2  Abl  ABL1  25  SH2  30464  7  7767  3  Abl R161L  ABL1  25  GST-SH2  6550  3  2504   4  Abl(R>K)  ABL1  25  GST-SH2  control  -1925  2  1575   5  Arg  ABL2  27  GST-SH2  141650  8  51616  6  Bks  BKS  55620  GST-SH2  -7350  9  10584  7  Blk  BLK  640  GST-SH2  -38745  10  38404  8  Blnk  BLNK  29760  GST-SH2  -2306  8  4926  9  Bmx  BMX  660  GST-SH2  9280  5  27443  10  Brdg1  BRDG1  26228  GST-SH2  -15340  5  19064  11  Brk  BRK  5753  GST-SH2  55065  13  15482  12  Btk  BTK  695  GST-SH2  -13840  5  17682   13  Cbl 2x  CBL  867  GST-SH2-SH2  41575  2  36925   14  CblA  CBL  867  GST-SH2  79625  10  86665  15  CblB  CBLB  868  GST-SH2  72481  13  28143  16  CblC  CBLC  23624  GST-SH2  30435  13  14982  17  Chimerin2  CHN2  1124  GST-SH2  9040  5  18935  18  Cis1  CISH  1154  GST-SH2  -1467  3  2967  19  Crk  CRK  1398  GST-SH2  -1081  8  16314  20  CrkL  CRKL  1399  GST-SH2  -406  8  27351  21  Csk  CSK  1445  GST-SH2  -3710  5  1578  22  Cten  TNS4  84951  GST-SH2  11900  12  3100  23  DAPP1  DAPP1  27071  GST-SH2  7786  7  4891  24  Dok1(PTB)  DOK1  1796  GST-PTB  10450  1  25  Eat2  SH2D1B 117157  GST-SH2  400  5  1627  26  Emt/Itk  ITK  3702  GST-SH2  28488  4  17625  27  Fer  FER  2241  GST-SH2  10450  5  8291  28  Fes  FES  2242  GST-SH2  -3088  4  2782  29  Fgr  FGR  2268  GST-SH2  9770  5  30224  30  Frk  FRK  2444  GST-SH2  1588  8  8569  31  Frs2(PTB)  FRS2  10818  GST-PTB  3400  1  32  FynA  FYN  2534  GST-SH2  98343  7  42717  33  Gap(C)  RASA1  5921  GST-SH2  8533  3  5172  34 Gap ( (Araki et al., 2004) ), were maintained in a mixed C57Bl/6J x 129/SvJ background. Some animals were crossed with Thy-1 GFP line M (https://www.jax.org/strain/007788, (Feng et al., 2000) ). We used male mice for all experiments, as dendritic spine density fluctuates with estrus (Woolley et al., 1990) , and made direct comparisons between paired littermates whenever possible. All animals were postnatal day (P) 40-P46 at the time of experiment unless noted otherwise. NS mice were genotyped using primers 5'-CAAGGTGAGTGGGCGTTTCATTTTAAC-3', 5'-ACCTTTCAGAGGTAGGGTCTGCAC-3', and 5'-CCATAGAGGTCATAGTAGCCACCG-3', which yield a 500 base pair product for the wild type allele and a 350 base pair product for the D61G allele. GFP genotyping is described by JAX (Bar Harbor, ME, https://www.jax.org/strain/007788).
# Probe

Novel object recognition.
The test was performed essentially as previously described (Kerrisk et al., 2013) . P42-56 WT and NS mice were habituated to the experimenter five minutes/day for five days, and to the testing environment (a large, empty cage in a quiet, dimly lit room) for one hour before testing. Mice were then allowed to explore the environment and two identical objects placed at either end of the long axis of the cage until they accumulated 30 seconds of object exploration time, defined as direct whisking or sniffing of the object. Mice were returned to their home cages and the test cages cleaned to remove scent cues. 48 hours later, mice were allowed to explore objects as on day one, except one object was replaced with a novel object. Mice were excluded if on either day, they failed to accumulate 30 seconds of object exploration time in six minutes of total exploration time or did not explore both objects. Exclusion rates were similar between genotypes. The object chosen as novel and its placement in the cage were randomized. Exploration was videotaped and scored manually by an experimenter blind to genotype and object novelty.
Hippocampal slice preparation and electrophysiological recordings. Slices were prepared and recordings made as previously described (Xiao et al., 2016) . Mice were deeply anesthetized with Nembutal and their brains rapidly removed and cooled in ice-cold sucrose-containing artificial cerebrospinal fluid (sucrose-ACSF, in mM): 2.5 KCl, 7 MgSO4•7H2O, 1.25 NaH2PO4, 0.5 CaCl2•2H2O, 28 NaHCO3, 7 dextrose, 205 sucrose saturated with 95% O2-5% O2 at 300-310 mOsmol/L, pH7.4. Transverse hippocampal slices were cut at 350 µm in ice-cold sucrose-ACSF on a vibratome (Leica, Wetzlar, Germany) and allowed to recover in a humidified, oxygenated environment at 33.5˚C for at least 30 minutes. Slices were perfused during recording at 1 mL/min with ACSF (in mM): 3 KCl, 1 MgSO4•7H-2O, 1.25 NaH2PO4, 2 CaCl2•2H2O, 26 NaHCO3, 10 dextrose, 118 NaCl, 0.4 ascorbic acid, 4 Na-lactic acid, 2 Napyruvic acid saturated with 95% O2-5% O2 at 300-310 mOsmol/L, pH7.4. 10 µM bicuculline methiodide (BMI), 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 3 µM ifenprodil, and 1 µM tetrodotoxin (TTX) (MilliporeSigma, Darmstadt, Germany) were included in the ACSF where described. CA1 pyramidal neurons were identified using DIC and infrared optics with a water-immersion objective (NIR Apo 40x; BX51, Nikon, Tokyo, Japan) at room temperature (RT), and whole-cell recordings were obtained with an Axopatch 700B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA) using recording electrodes pulled from 1.5 mm glass capillaries on a Flaming-Brown micropipette puller (Sutter Instruments, Novato, CA) filled with (in mM): 137 cesium gluconate, 10 NaCl, 0.2 EGTA, 4 Na2ATP, 0.3 Na3GTP, 5 Na2-phosphocreatine, 10 HEPES, 5 QX-314 chloride adjusted to 290-300 mOsmol/L pH7.4. Under these conditions, the recording electrodes had a resistance of 4-7 MΩ. Recombinant GST-Nck2 SH2 domain protein was included in the patch solution at 2.5 or 5 µg/mL where described. Currents were low pass filtered at 2 kHz and digitized at 5 kHz with a Digidata 1440 digitizer (Molecular Devices). Cells were excluded if series resistance deviated >20% or exceeded 20 MΩ. Data were collected in pClamp 10.3 and analyzed with Clampfit 10.3. For all data, n=number of neurons.
Excitatory postsynaptic currents (EPSCs) were evoked with 0.05 Hz stimulation by a tungsten bipolar stimulating electrode placed ~150 µm away from the recording electrode in the Schaffer collateral using stimulus intensities that yielded 50-60% of the maximal response. AMPAR-EPSC amplitudes were measured at the peak of the EPSC recorded at -70 mV holding potential. NMDAR-EPSC amplitudes were recorded from the same neurons at +40 mV 40 ms after the stimulus artifact, after AMPAR-EPSCs have decayed (Choi et al., 2000) . NMDAR-EPSC decay kinetics were measured using a nonlinear regression in pClamp to fit recordings with a double exponential decay ( ) = fast ()/+ fast + slow ()/+ slow , where ( ) is the amplitude of the EPSC at time t, Ifast and Islow are the peak amplitudes of the fast and slow components, respectively, and tfast and tslow are their respective time constants. Weighted time constants were calculated from the time constants and relative amplitudes of the two exponential components. To determine GluN2B contribution, tweighted was calculated from NMDAR-EPSCs recorded under baseline conditions and from the same neurons after addition of 3 µM ifenprodil. Long-term potentiation of evoked EPSCs (recorded at -70 mV) was induced by theta-burst stimulation (five trains of four pulses at 100 Hz in 200 ms intervals, repeated four times with an interval of 10 s) in the presence of 10 µM BMI.
Miniature EPSCs (mEPSCs) were recorded in whole-cell patch mode. AMPAR-mEPSCs were recorded at -70 mV with TTX and BMI in the external solution, and NMDAR-mEPSCs were recorded at -40 mV with TTX, BMI, and CNQX with low Mg 2+ (0.1 mM) and high Ca 2+ (3.8 mM) to partially remove the Mg 2+ block. Amplitude, frequency, and decay time of miniature events were detected using Mini-Analysis software (Synaptosoft, Decatur, GA), and inspected visually to exclude overlapping events and events on a noisy baseline. NMDAR-mEPSC tweighted was calculated as described above.
CA1 neuron anatomy.
For all anatomical analyses, data were acquired and analyzed by an experimenter blind to genotype and region, and measured essentially as previously described (Kerrisk et al., 2013; Sfakianos et al., 2007; Warren et al., 2012) . To measure dendrite morphology, acute 400 µm hippocampal slices were cut as described above and recovered for at least 1 hour in an interface chamber at 31˚C. Single CA1 pyramidal neurons were injected with 4% biocytin in 2 M potassium acetate pH7.5 with 200 ms current injections of 4 nA at 2 Hz for 20 minutes. Neurons were excluded if they did not maintain membrane potential or action potential firing during biocytin injection. Slices were fixed with 4% paraformaldehyde (PFA) in PBS, cryoprotected in 30% sucrose, resectioned to 40 µm on a sliding microtome, and stained with avidin-HRP and DAB (Vectastain Elite ABC, Vector Laboratories, Burlingame, CA). Filled neurons in serial sections were traced under 100x magnification on a light microscope outfitted with a zdrive and reconstructed using Neurolucida (MBF Bioscience, Williston, VT). Neurons that did not have a dendritefree section at both ends of the z-stack were excluded. Dendrite length and branch-point numbers were calculated using NeuroExplorer. n=number of neurons, with ≤ 5 neurons sampled from each of 5-8 animals. Outliers were identified as values greater than 1.5x the interquartile distance below the first or above the third quartile and excluded.
To measure dendritic spine density, WT and NS littermates carrying the Thy1-GFP:M transgene were deeply anesthetized with Nembutal and transcardially perfused with 4% PFA/PBS. Brains were dissected and postfixed overnight. Vibratome-cut 40 µm tissue sections were imaged with a 100x oil immersion objective on an UltraVIEW VoX (Perkin Elmer, Waltham, MA) confocal microscope (Nikon Ti-E Eclipse) with Volocity software (Improvision, Coventry, UK). Spines were counted manually in the z-stack in Fiji (Schindelin et al., 2012) , and 3D dendrite segment length was measured using the Simple Neurite Tracer Fiji plugin (Longair et al., 2011) . All spines analyzed were on terminal oblique dendrites of the main apical dendrite of CA1 pyramidal neurons and located either proximal to the soma in stratum radiatum or distal to the soma just basal to stratum lacunosum. All dendrite segments were at least 30 µm long and of similar diameter. n=average spine density per mouse, with 5-8 dendrite segments analyzed per animal per region.
To measure spine ultrastructure, WT and NS littermates were perfused with 4% PFA/2% glutaraldehyde and their brains postfixed and sectioned to 50 µm as above. Brain slices were processed in 4% OsO4 for 1 hour and dehydrated in a series of increasing ethanol dilutions and propylene oxide. Contrast was improved by staining with 1% uranyl acetate in 70% ethanol for 1 hour before resectioning, and by staining with lead citrate after resectioning. Tissue was resectioned with an ultramicrotome at 70 nm after embedding in Epon, and sections were collected on Formvar coated slot grids and viewed using a JEOL 1200 EX Electron Microscope at 12,000 X magnification. Images were analyzed in Fiji. Mushroom-shaped spine heads with an electron dense post-synaptic density (PSD) apposed to a presynaptic terminal containing synaptic vesicles were counted as synapses. PSD length was measured from these synapses. Spine head area was measured to the thinnest part of the spine neck only from spines with a clear neck. Synapse density n=average synapse density per mouse, averaged from 16-18 images per animal. Spine head areas and PSD lengths were quantified with n=number of spine heads/PSDs. DNA constructs. WT and D425A human SHP2 protein tyrosine phosphatase domain (PTP) (amino acids 218-528) in pGEX-2TK have been previously described (Kolli et al., 2004) . The Q506A mutation was introduced into the D425A construct by site-directed mutagenesis. Mouse SHP2 cDNA was purchased from Open Biosystems (cat# MMM1013-9200724, GE Dharmacon, Lafayette, CO). To make full-length GST-mSHP2 pFastbac, mSHP2 cDNA was PCR amplified and ligated into GST-pFastBac1 (Bac-to-Bac, Thermo Fisher Scientific, Waltham, MA), a modified pFastBac1 with GST inserted between the BamHI and EcoRI sites, and the D61G and C459S mutations were introduced with site-directed mutagenesis. To make MBP-GluN2B C3-His pMAL-TEV, the sequence coding amino acids 1240-1482 of mouse GluN2B was PCR amplified from GluN2B cDNA (using a 3' primer coding a 6xHis tag) and ligated into pMAL-TEV (NEB, Ipswich, MA). YFP-GluN2B pVivo2.5 and GluN1-1a GW were gifts of AnnMarie Craig (University of British Columbia). To make YFP-GluN2B pcDNA3.1+, the YFP-GluN2B coding sequence was PCR amplified and ligated into pcDNA3.1+ (Thermo). To make untagged GluN2B pcDNA3.1+ used for single channel recordings, the GluN2B coding sequence was subcloned into pcDNA3.1+ from mouse GluN2B cDNA, and Y1252F and Y1252E mutations were introduced with site-directed mutagenesis. Mouse GluN1 pCMV (UniprotKB P35438) used for experiments on recombinant receptors was a gift of Gabriela Popescu (University at Buffalo, SUNY). To make GST-∆85-C-Src, the sequence coding amino acids 86-C terminus of Src kinase was PCR amplified from mouse Src pcDNA3.1+ and ligated into GST-pFastBac1. The ∆85C mutant lacks the first 85 amino acids and is constitutively active (Jeansonne et al., 2006) . GST-Nck2 SH2 domain has been previously described (Machida et al., 2007) , and the R311K mutation was introduced with site-directed mutagenesis. Myc-mouse Nck2 (accession NM_010879) pCMV-Entry was obtained from Origene, and eGFP-N1 was purchased from Clontech. All cloning was confirmed by sequencing.
Western blotting. Rabbit anti pY1252, pY1336, and pY1472 (cat# p1516-1252 Rabbit anti pY1252, pY1336, and pY1472 (cat# p1516- , -1336 Rabbit anti pY1252, pY1336, and pY1472 (cat# p1516- , and -1472 ; each used at 1:1000) are from PhosphoSolutions (Aurora, CO), mouse anti GluN2B clone N59/20 (75-097; 1:2000) is from the UC Davis/NIH NeuroMab Facility (Davis, CA), mouse anti SHP2 clone 79 (610621; 1:5000) and mouse anti GluN2A clone 5 (612286; 1:1000) are from BD Biosciences (San Jose, CA), rabbit anti GluN2B c-terminus (06-600; 1:1500), rabbit anti GluA1 (ABN241; 1:1000), and mouse anti actin clone C4 (MAB1501; 1:100,000) are from MilliporeSigma, mouse anti HSP70 clone 3A3 (sc-32239; 1:10,000) is from Santa Cruz (Dallas, TX), rabbit anti GluN1 clone D65B7 (5704; 1:1000) and rabbit anti Myc-tag (2272; 1:1000) are from Cell Signaling Technologies (Danvers, MA), and mouse anti phosphotyrosine clone 4G10 was purified from a hybridoma to 1 mg/ml and diluted (1:2000) . Secondary antibodies goat anti-rabbit IgG (H+L)-HRP conjugate (1721019) and goat anti-mouse IgG (H+L)-HRP conjugate (1721011) (1:5000 each) are from Biorad (Hercules, CA). For all western blots, samples were separated by 8% or 10% SDS-PAGE and transferred to 0.2 µm nitrocellulose (Biorad) at 35V for 720 minutes at 4˚C, and uniform transfer and equal loading were confirmed by Ponceau S stain. Blots were blocked at RT in 5% non-fat dry milk in Trisbuffered saline with 0.05% Tween-20 (TBST) for all antibodies except those against phosphotyrosines, which were blocked in 5% bovine serum albumin in TBST, then probed overnight at 4˚C with indicated primary antibodies at the dilutions above in 5% BSA/TBST. Blots were washed with TBST, probed at RT with the appropriate secondary antibody in 5% milk/TBST, washed again, and proteins detected with enhanced chemiluminescence. Bands on scanned films were quantified in Fiji.
Surface biotinylation. All steps were carried out at 4˚C or on ice. WT and NS littermates were deeply anesthetized with Nembutal, decapitated, and their hippocampi rapidly dissected. Whole hippocampus was incubated 10 minutes in PBSCM (1x PBS, 1 mM MgCl2, 0.1 mM CaCl2 pH8.0) containing 0.5 mg/ml NHS-LC-biotin (Thermo), or in PBSCM without biotin as a control. Tissue was washed 5 minutes in PBSCM + 20 mM glycine to neutralize excess biotin and once with PBSCM alone, and finally homogenized in RIPA buffer (25 mM Tris pH7.5, 250 mM NaCl, 5% glycerol, 1 mM EDTA, 1% TX100, 0.1% SDS, 0.5% sodium deoxycholate, plus protease (1 mM PMSF, 20 µg/mL aprotinin, 1 mM benzamidine, 10 µg/mL each pepstatin A, leupeptin, and chymostatin) and phosphatase (1 mM sodium orthovanadate, 2 mM NaF) inhibitors), rotated for 10 minutes, and cleared at 14K RPM in a tabletop centrifuge. Protein concentration was determined by BCA assay (Thermo). 100 µg of protein was incubated overnight with 50 µl Neutravidin resin (Thermo), and 10 µg of protein reserved for input. The resin was washed 4 x 5 minutes with RIPA buffer then resuspended in 1x SDS-PAGE sample buffer (25 mM Tris pH6.8, 2% SDS, 5% glycerol, 2% beta-mercaptoethanol), and inputs were solubilized by addition of 4x sample buffer to 1x. Samples were eluted/solubilized by heating to 65˚C for 10 minutes and then western blotted as described above. All comparisons were made between paired littermates biotinylated in the same solutions. Data are presented as a surface/total ratio, and normalized to the WT average.
Recombinant protein.
For all proteins, concentration was determined by Bradford assay (Biorad) and purity by Coomassie Blue stained SDS-PAGE gels, and protein was aliquoted, snap frozen in liquid nitrogen, and stored at -80˚C until use. GST-SHP2 PTP domains were produced in Rosetta E. coli (Novagen, Madison, WI) by inducing protein expression with 0.3 mM IPTG overnight at 18˚C. Bacteria were collected by centrifugation, resuspended in lysis buffer (50 mM Tris pH8, 150 mM NaCl, 5% glycerol, 1 mM EDTA, 5 mM DTT, 1% TX100, protease inhibitors) and lysed with a probe sonicator. Insoluble material was removed by centrifugation at 150,000 x g for 45 minutes. The soluble lysate was incubated with glutathione agarose resin (Thermo) for 1 h, then washed with: buffer A (lysis buffer with 500 mM NaCl and no EDTA), buffer B (buffer A with 100 mM Tris pH8.0, 10 mM ATP, 5 mM MgCl2, and 0.1% TX100), buffer C (buffer B with 150 mM NaCl and no TX100), and buffer D (50 mM Tris pH8.0, 150 mM NaCl, 5% glycerol, 1 mM DTT, 1 mM PMSF). The resin was packed into a column and bound protein eluted with 10 mM glutathione in buffer D, and peak fractions were dialyzed into fresh buffer D to remove glutathione.
